Yuqing Huo | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Yuqing Huo | Cardiovascular Pharmacology | Best Researcher Award

Baylor College of Medicine | United States

Prof. Yuqing Huo, Ph.D., is a distinguished cardiovascular and vascular biology researcher whose work bridges molecular mechanisms and clinical applications in inflammation, angiogenesis, and metabolic disease. A U.S. citizen with an extensive background in biomedical science, he currently serves as Professor and Danny B. Jones Chair at the Department of Ophthalmology, Department of Medicine/Section of Cardiovascular Research, and Department of Molecular and Cellular Biology at Baylor College of Medicine in Houston, Texas. His academic journey has been defined by a lifelong dedication to understanding vascular inflammation, endothelial function, and cellular metabolism in cardiovascular and ocular diseases.Prof. Huo earned his Medical Degree from Jining Medical College, followed by a Master’s in Cardiology from Qingdao University and a Doctoral Degree in Molecular Cardiology from Beijing Medical University. He further advanced his expertise as a Postdoctoral Research Associate in Inflammation and Vascular Biology at the University of Virginia, where he worked in Dr. Klaus Ley’s renowned laboratory at the Cardiovascular Research Center. His postdoctoral research laid the foundation for his later breakthroughs in vascular inflammation, monocyte recruitment, and endothelial interactions in atherosclerosis.Over his distinguished academic career, Prof. Huo has held faculty positions at several leading institutions, including the University of Virginia, the University of Minnesota, and Augusta University, where he served as Professor, Chief of the Vascular Inflammation Program, and Director of the Vision Discovery Institute. His leadership in the field has shaped numerous interdisciplinary programs that integrate cardiovascular and ocular research, expanding the understanding of inflammation and angiogenesis in chronic diseases.His scientific achievements have been widely recognized through numerous honors and awards, including distinctions from the American Heart Association, the American Physiological Society, and the American Diabetes Association. His accolades include the New Investigator Award, Young Investigator Award, and several institutional honors for outstanding research contributions and academic excellence.Prof. Huo’s active research focuses on “Myeloid glycolysis in pathological ocular angiogenesis,” “Myeloid PFKFB3 in subretinal fibrosis,” “Adenosine receptor 2A in subretinal fibrosis,” and “VSMC PFKFB3 in atherogenesis,” among others. His projects, supported by the National Institutes of Health (NIH) and the American Heart Association (AHA), aim to uncover novel molecular targets that regulate inflammation, fibrosis, and vascular remodeling. Through the use of genetically engineered models and molecular approaches, his research explores glycolytic reprogramming in immune cells and vascular tissues, paving the way for innovative therapeutic strategies in cardiovascular, metabolic, and ocular disorders.

Profile: Google Scholar

Featured Publications

Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D. Z., Lu, Q., Deitch, E. A., Huo, Y., Delphin, E. S., & Zhang, C. (2009). MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circulation Research, 105(2), 158–166.

Huo, Y., Hafezi-Moghadam, A., & Ley, K. (2000). Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circulation Research, 87(2), 153–159.

Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. F. (2003). Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nature Medicine, 9(1), 61–67.

Luo, X., Li, H., Ma, L., Zhou, J., Guo, X., Woo, S. L., Pei, Y., Knight, L. R., Deveau, M., Yang, S., & Huo, Y. (2018). Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology, 155(6), 1971–1984.e4.

Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D. C., & Liao, J. K. (1999). Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science, 285(5431), 1276–1279.

Ramos, C. L., Huo, Y., Jung, U., Ghosh, S., Manka, D. R., Sarembock, I. J., & Ley, K. (1999). Direct demonstration of P-selectin– and VCAM-1–dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E–deficient mice. Circulation Research, 84(11), 1237–1244.

Ameni Gouider | Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Ameni Gouider | Formulation Science | Best Researcher Award

Faculty of Sciences of Gabes | Tunisia

Ms. Ameni Gouider is an emerging researcher in electrochemical water treatment and environmental chemistry, dedicated to developing sustainable solutions for the remediation of industrial effluents, particularly from the pharmaceutical sector. She is currently pursuing a Doctorate in Water Treatment by Electrochemistry at the Faculty of Sciences of Gabès, Tunisia, where her research centers on advanced electrochemical processes for treating pharmaceutical wastewater. Her doctoral work reflects a deep commitment to environmental protection and technological innovation, with a focus on optimizing electrochemical and membrane-based systems for effective pollutant removal.As part of her ongoing research, Ms. Gouider is conducting a research internship at the CNRS / Institut Européen des Membranes in Montpellier, France. Her current project explores the integration of electrochemical and membrane technologies for the depollution of complex industrial effluents, bridging the gap between laboratory research and real-world environmental applications. Her scientific curiosity and methodological precision allow her to design, test, and model innovative approaches that contribute to the global effort toward sustainable water management.Ms. Gouider holds a Master’s degree in Materials and Environmental Chemistry and a National License in Chemistry from the Faculty of Sciences of Gabès, following a solid foundation in experimental sciences acquired during her early studies. Her academic path has equipped her with strong analytical, experimental, and statistical skills, including expertise in advanced experimental design, response surface methodology, multivariate optimization, and analysis of variance (ANOVA). She is proficient in using specialized software such as Nemrod and Microsoft Office tools for data analysis, scientific reporting, and presentation.Her publication titled “Treatment of pharmaceutical industry effluent using conventional and pulsed electrocoagulation on iron electrodes: Optimization using response surface methodology” published in Total Environment Engineering (Elsevier) highlights her innovative approach in applying electrochemical methods to optimize effluent treatment processes. This work demonstrates her ability to combine theoretical modeling with experimental validation to enhance the performance and sustainability of industrial water treatment systems.Ms. Gouider’s research has been presented at several national and international scientific events, including Euro-Africa Congresses and water-related scientific forums, where she actively contributes to discussions on environmental protection and technological advancement. Known for her organizational skills, teamwork, and dedication, she continues to pursue excellence in scientific communication, applied research, and interdisciplinary collaboration, driven by her vision of creating cleaner technologies for a sustainable future.

Profile: Orcid

Featured Publications

Gouider, A., Zaabtia, A., Khalifa, M., Ba, M., & Ammar, S. (2025). Treatment of pharmaceutical industry effluent using conventional and pulsed electrocoagulation on iron electrodes: Optimization using response surface methodology. Total Environment Engineering, 100048.

Ruby Anto | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Ruby Anto | Drug Discovery and Development | Best Researcher Award

Centre of Excellence in Nutraceuticals | India

Dr. Ruby Anto is a distinguished biochemist and cancer researcher with an extensive career dedicated to advancing the fields of molecular oncology, bioimmunotherapy, and nutraceutical science. She currently serves as Chief Scientist at the Centre of Excellence in Nutraceuticals, KSCSTE, Government of Kerala, Thiruvananthapuram, and Honorary Scientist at the Institute of Advanced Virology, Thiruvananthapuram. Over her accomplished career, she has held numerous scientific positions at the Rajiv Gandhi Centre for Biotechnology, progressing from Research Associate to Scientist G, reflecting her consistent contributions and leadership in biomedical research.Dr. Anto earned her PhD in Biochemistry from Amala Cancer Research Centre, Thrissur, following her postgraduate studies in Chemistry and Education. Her multidisciplinary academic background—combining chemistry, biochemistry, and pedagogy—has been central to her innovative approach to cancer biology and molecular medicine. Her early academic achievements and later professional experiences at prestigious institutions such as the M.D. Anderson Cancer Center, Houston, provided a strong foundation for her research on targeted cancer therapies, chemopreventive agents, and the role of natural products in disease modulation.Recognized nationally and internationally for her scientific excellence, Dr. Anto has received several prestigious honors, including the Young National Women Bio-Scientist Award from the Department of Biotechnology, Government of India, and fellowships from the National Academy of Sciences, India, and the Academy of Sciences, Thiruvananthapuram. Her professional journey also includes global training experiences, such as her participation in the Clinical Trials Traineeship Program at INSERM, Paris, which broadened her expertise in translational research and clinical validation of nutraceutical interventions.As a mentor, Dr. Anto has nurtured a generation of young scientists, with her students and postdoctoral fellows earning numerous national and international awards for their work in cancer biology and nutraceutical research. Her leadership has fostered a thriving academic environment focused on the discovery and characterization of bioactive compounds from natural sources with therapeutic potential.Dr. Anto’s scientific publications have advanced understanding in areas such as natural compound-mediated cancer prevention, signaling pathway modulation, and anti-inflammatory mechanisms of nutraceuticals. Through her research, she continues to bridge the gap between basic biochemistry and applied health sciences, promoting nutraceutical innovation as a cornerstone of preventive and personalized medicine. Her lifelong dedication to scientific inquiry and mentorship underscores her status as one of India’s leading voices in biochemistry and nutraceutical research.

Profile: Google Scholar

Featured Publications

Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., & Kuttan, R. (1995). Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letters, 94(1), 79–83.

Anto, R. J., Mukhopadhyay, A., Denning, K., & Aggarwal, B. B. (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23(1), 143–150.

Anto, R. J., Sukumaran, K., Kuttan, G., Rao, M. N. A., Subbaraju, V., & Kuttan, R. (1995). Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Letters, 97(1), 33–37.

Oommen, S., Anto, R. J., Srinivas, G., & Karunagaran, D. (2004). Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells. European Journal of Pharmacology, 485(1–3), 97–103.*

Anto, R. J., Mukhopadhyay, A., Shishodia, S., Gairola, C. G., & Aggarwal, B. B. (2002). Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: Correlation with induction of cyclooxygenase-2. Carcinogenesis, 23(9), 1511–1518.*

Bava, S. V., Puliappadamba, V. T., Deepti, A., Nair, A., Karunagaran, D., & Anto, R. J. (2005). Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κB and the serine/threonine kinase Akt and is independent of tubulin polymerization. Journal of Biological Chemistry, 280(8), 6301–6308.*

Srinivas, G., Anto, R. J., Srinivas, P., Vidhyalakshmi, S., Senan, V. P., & Karunagaran, D. (2003). Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9. European Journal of Pharmacology, 473(2–3), 117–125.*

Jiaojiao Liang | Herbal Medicine and Nutraceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Jiaojiao Liang | Herbal Medicine and Nutraceuticals | Best Researcher Award

Weihai Agricultural and Rural Affairs Service Center | China

Dr. Jiaojiao Liang is an accomplished agronomist with a profound research focus on fruit nutrition and consumption guidance. She earned her doctoral degree from Zhejiang University, where she was directly admitted to the Ph.D. program through postgraduate recommendation, a recognition of her outstanding academic performance and research potential. Her academic journey has been deeply rooted in the field of Pomology, where she has dedicated herself to exploring the nutritional value and functional benefits of fruits, with a particular emphasis on the extraction and utilization of natural bioactive compounds.Dr. Liang’s scientific endeavors primarily revolve around the identification and functional evaluation of natural products derived from fruits, such as flavonoids in citrus peels and anthocyanins in specialty berries. Her research integrates modern analytical techniques with biological evaluation models to uncover the therapeutic potential of these compounds in combating oxidative stress, inflammation, and cellular damage. Through her studies, she has provided new insights into the use of fruit-derived bioactives as potential dietary interventions for health promotion and disease prevention.As an emerging scholar in her field, Dr. Liang ohas co-authored several impactful publications in highly regarded scientific journals, including Food Chemistry, Critical Reviews in Food Science and Nutrition, Food Frontiers, and Food Science & Nutrition. Her works have explored diverse topics such as the protective effects of anthocyanin extracts from superfruits against cadmium-induced oxidative stress, the apoptotic mechanisms of limonin in cancer cells, and the hepatoprotective potential of flavonoid-rich fruit extracts. Her review on nobiletin as a chemopreventive natural product has been particularly noted for its comprehensive synthesis of current advancements in phytochemical research.Dr. Liang has also contributed significantly to collaborative research initiatives, particularly with the Hainan Institute of Zhejiang University, where she has participated in both completed and ongoing projects examining the bioactivity of flavonoids under environmental stress conditions. Her work in establishing cellular models to evaluate antioxidant enzyme activities, inflammatory biomarkers, and gene expression has strengthened the understanding of how fruit-based compounds interact with human biological systems.

Profile: Orcid

Featured Publications

Chen, Y.-Y., Liang, J.-J., Wang, D.-L., Chen, J.-B., Cao, J.-P., Wang, Y., & Sun, C.-D. (2023). Nobiletin as a chemopreventive natural product against cancer: A comprehensive review. Critical Reviews in Food Science and Nutrition.

Zuzana Sekeyová | Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Mrs. Zuzana Sekeyová | Formulation Science | Best Researcher Award

Slovak Academy of Sciences | Slovakia

Mrs. Zuzana Sekeyová is a highly accomplished virologist and microbiologist with extensive expertise in the study, diagnosis, and prevention of rickettsial and intracellular pathogens. She obtained her Bachelor’s and Master’s degrees in Virology from Comenius University, Bratislava, and completed her Ph.D. at the Faculty of Natural Sciences, Comenius University, focusing on the biology of Rickettsiae and related organisms at the Institute of Virology, Slovak Academy of Sciences. She advanced her knowledge through postdoctoral training at the University of Maryland, Department of Microbiology and Immunology, Baltimore, USA, and through multiple visiting research fellowships supported by the Deutsche Akademische Austauschdienst (DAAD) at Justus Liebig Universität, Giessen, Germany, and the WHO Collaborative Center for Rickettsial Reference and Research, CNRS UPRESA 6020, Marseille, France. She further enhanced her global expertise as a visiting research fellow with the Japan Society for the Promotion of Science at Obihiro University of Agriculture & Veterinary Medicine and the National Institute of Infectious Diseases in Tokyo, Japan.Mrs. Sekeyová began her career as a scientific assistant and young scientist at the Institute of Virology, Slovak Academy of Sciences, progressing to senior research scientist and deputy head of the Department of Rickettsiology, where she currently oversees the Laboratory for Diagnosis and Prevention of Rickettsial and Chlamydial Infections. She serves as an expert verifier for the Slovak National Accreditation Service under the Good Laboratory Practice Compliance Program and is a key member of the National Reference Center for Surveillance and Laboratory Diagnostics of Rickettsiae. She is also an internationally recognized expert in synthetic biology, participating in the Open Ended Online Forum and the Ad Hoc Technical Expert Group under the United Nations Convention on Biological Diversity.Her research emphasizes the molecular biology, epidemiology, and diagnostics of rickettsial and related intracellular microorganisms, contributing to innovative detection methods and preventive strategies. Notable publications include Evaluation of cytotoxic activity against A549 human lung cancer cells using green synthesized N-Cholyl D-Penicillamine encapsulated silver and gold nanoparticles, Mucoadhesive and drug release of cholic acid based thiomeric micelles and encapsulated silver and gold nanoparticles for anticancer studies, and C-type natriuretic peptide induces cell death and sensitizes the effect of cisplatin in human non-small cell lung cancer cells. Through decades of research, Mrs. Sekeyová has combined rigorous laboratory investigations with translational and global health applications, establishing herself as a leading authority in virology, rickettsial diseases, and synthetic biology, with a strong commitment to advancing international scientific collaboration and public health initiatives.

Profile: Orcid

Featured Publications

Špitalská, E., Sabaka, P., Komorníková, A., Minichová, L., Palkovičová, K., Fenollar, F., Škultéty, Ľ., Miková, E., Sekeyová, Z., & Fournier, P.-E. Abdominal manifestations of Q fever. International Journal of Infectious Diseases.

Danchenko, M., Benada, O., Škultéty, Ľ., & Sekeyová, Z. Culture Isolate of Rickettsia felis from a Tick. International Journal of Environmental Research and Public Health.

Sekeyová, Z. Case studies of rickettsiosis, anaplasmosis and Q fever in Slovak population from 2011 to 2020. Biologia.

Sekeyová, Z. Detection of Rickettsia raoultii in Dermacentor reticulatus and Haemaphysalis inermis ticks in Slovakia. Biologia.

Sekeyová, Z. Hymenopteran Parasitoids of Hard Ticks in Western Africa and the Russian Far East. Microorganisms.

Gopinath Nagaraj | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Gopinath Nagaraj | Pharmacology | Best Researcher Award

University of Madras | India

Dr. Gopinath Nagaraj is an accomplished biochemist and molecular biologist specializing in cardiovascular research, with a particular focus on elucidating the molecular mechanisms underlying cardiac hypertrophy and heart failure. He earned his Ph.D. in Biochemistry from the University of Madras under the mentorship of Prof. Elangovan Vellaichamy, where his doctoral research explored the intricate molecular pathways governing cardiac hypertrophy through both in vitro and in vivo models. His expertise encompasses a wide range of cellular and molecular biology techniques, including qPCR, Western blotting, ELISA, FACS analysis, and fluorescence microscopy, all of which he has skillfully applied to investigate receptor signaling mechanisms and molecular cardiology.Dr. Gopinath’s pioneering research centers on the natriuretic peptide receptor-A (NPR-A/GC-A) signaling pathway and its modulation in cardiovascular physiology. His studies provide valuable insights into how NPR-A expression, internalization, and trafficking dynamics regulate receptor function and contribute to cardiovascular homeostasis. Through his innovative integration of experimental and computational methods—such as molecular docking and receptor trafficking assays—he has advanced understanding of how natural compounds like curcumin modulate receptor function and restore cellular signaling in stress-induced cardiac hypertrophy and inflammation models. This approach bridges receptor biology with natural product pharmacology, opening new therapeutic possibilities for cardiovascular disease management.His notable publications include Triiodo-L-thyronine Downregulates Npr1 Gene Transcription in H9c2 Cells: Involvement of β-AR-ROS Signaling published in Endocrine; C-Type Natriuretic Peptide Induces Cell Death and Sensitizes the Effect of Cisplatin in Human Non-Small Cell Lung Cancer Cells in International Journal of Peptide Research and Therapeutics; CNP Inhibits T3-Induced Hypertrophic Growth in H9c2 Cells: Impact of HDAC Inhibitor in Archives of Biochemistry and Biophysics; Curcumin with ANP Treatment Enhances the Internalization and Trafficking of NPR-A Mediated Signaling Pathway in Tissue and Cell; and Epigenetic Modulation of Natriuretic Peptide Receptor Signaling by HDAC Inhibitors in Thyroxine-Induced Cardiac Hypertrophy submitted to the European Journal of Pharmacology. Dr. Gopinath has contributed expert consultancy in receptor signaling and preclinical molecular evaluation for bioactive compounds, polymers, and nanoparticles with cardioprotective, anticancer, and anti-inflammatory properties. With multiple ongoing research projects, five publications in high-impact journals, and an h-index of three, he continues to strengthen the translational link between molecular cardiology and therapeutic innovation. His role as a reviewer for Discover Oncology further reflects his commitment to upholding scientific integrity and excellence in biomedical research. Through his innovative research, multidisciplinary collaborations, and translational insights, Dr. Gopinath exemplifies scientific dedication in advancing cardiovascular and molecular biosciences.

Profile: Google Scholar

Featured Publications

Elumalai, M., Nagaraj, G., Kasthuri, J., Vellaichamy, E., & Rajendiran, N. Evaluation of cytotoxic activity against A549 human lung cancer cells using green synthesized N-Cholyl D-Penicillamine encapsulated silver and gold nanoparticles. Inorganic Chemistry Communications, 153, 110834.

Baskaran, A., Elumalai, M., Nagaraj, G., Vellaichamy, E., & Rajendiran, N. Mucoadhesive and drug release of cholic acid-based thiomeric micelles and encapsulated silver and gold nanoparticles for anticancer studies. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 703, 135363.

Nagaraj, G., Dhanusu, S., Nachiappan, D. M., & Vellaichamy, E. C-type natriuretic peptide (CNP) induces cell death and sensitizes the effect of cisplatin in human non-small cell lung cancer cells (A549). International Journal of Peptide Research and Therapeutics, 28(4), 112.

Nagaraj, G., & Vellaichamy, E. Triiodo-L-thyronine (T3) downregulates Npr1 gene (coding for natriuretic peptide receptor-A) transcription in H9c2 cells: involvement of β-AR-ROS signaling. Endocrine, 85(3), 1075–1090.

Nagaraj, G., & Vellaichamy, E. CNP inhibits T3-induced hypertrophic growth in H9c2 cells: Impact of HDAC inhibitor. Archives of Biochemistry and Biophysics, 110648.

Elumalai, M., Nagaraj, G., Ramaraj, S. G., Vellaichamy, E., Tabata, H., & Rajendiran, N. NCPA-templated red-emitting gold nanoclusters: a turn-off-on fluorescent probe for rapid and selective detection of Cu²⁺ ions in live cells and evaluation of biological applications. Dalton Transactions (Cambridge, England: 2003).

Galal Elgemeie | Medicinal Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Galal Elgemeie | Medicinal Chemistry | Best Researcher Award

Helwan University | Egypt

Prof. Elgemeie stands as a distinguished figure in the field of organic and medicinal chemistry, with a research career deeply rooted in the development and mechanistic understanding of organic reactions and their applications in synthesizing antimetabolic agents. His scholarly pursuits bridge fundamental chemistry with biomedical innovation, particularly in the discovery of novel therapeutic compounds aimed at combating cancer and viral diseases. Through his extensive academic contributions, he has established a legacy of excellence that continues to inspire scientists and researchers globally.An internationally recognized scientist, Prof. Elgemeie was elected as a member of the Scientific Board of the International Basic Sciences Programme (IBSP) under UNESCO in Paris, France, reflecting his global influence and leadership in advancing the chemical sciences. His postdoctoral experiences across Germany, the United States, and England—supported by prestigious foundations such as the Alexander von Humboldt Foundation, the Fulbright Program, and the British Council—shaped his multidisciplinary expertise and broadened his research collaborations across continents.Prof. Elgemeie’s innovative research has led to numerous impactful projects, including the design and synthesis of novel epigenetic small molecules and antimetabolites in collaboration with the Institute of Medicinal Chemistry, Düsseldorf University. His pioneering work in developing sofosbuvir analogues for treating hepatitis C virus (HCV) and hepatocellular carcinoma among Egyptian patients demonstrates his commitment to translating scientific discovery into therapeutic applications with real-world benefits.His publication record is exceptional, with over 270 papers indexed in international databases such as Scopus, and his scientific influence is further underscored by a significant citation index. He has authored influential scientific books with leading publishers like Elsevier, offering comprehensive insights into cancer metabolism and heterocyclic chemistry. Prof. Elgemeie also holds several patents in process, reflecting his drive to innovate beyond academia and contribute to industry-based advancements in medicinal chemistry.Serving as an editorial board member for prominent journals including Current Microwave Chemistry, he continues to guide the global scientific dialogue in his field. His collaborations span several institutions worldwide, reinforcing his reputation as a bridge between Egyptian and international research communities.Beyond research, Prof. Elgemeie has played a vital role in educational reform and academic development across Egypt and the Arab region. He has supervised multiple cooperative projects with the European Community under the TEMPUS programme, contributing to the restructuring of higher education and aligning it with international standards. These initiatives have significantly advanced institutional capacity and innovation within Mediterranean and Arab universities.

Profile: Orcid

Featured Publications

Azzam, R. A., Seif, M. M., El-Demellawy, M. A., & Elgemeie, G. H. (2025). Novel 2-substituted benzothiazole derivatives: Synthesis, in vitro and in silico evaluations as potential anticancer agents. RSC Advances.

Elgemeie, G. H., Fathy, N. M., & Shaarawi, S. I. (2024). Naphthyl cyanoketene N, S-acetals in glycoside synthesis: A new preparative route to a new class of N-naphthylcyanoacrylamide thioglycosides and their conversions to naphthyl–pyrazole hybrids. Nucleosides, Nucleotides & Nucleic Acids.

Abu-Zaied, M. A., Nawwar, G. A., & Elgemeie, G. H. (2024). Novel synthesis of a new class of substituted S-glycosylisothiourea derivatives and their conversion to 5-amino-1,2,4-triazoles. Synthetic Communications.

Metwally, N. H., Elgemeie, G. H., & Fahmy, F. G. (2023). Synthesis and biological evaluation of benzothiazolyl-pyridine hybrids as new antiviral agents against H5N1 bird flu and SARS-CoV-2 viruses. ACS Omega.

Abdallah, A. E. M., Abdel-Latif, S. A., & Elgemeie, G. H. (2023). Novel fluorescent benzothiazolyl-coumarin hybrids as anti-SARS-COVID-2 agents supported by molecular docking studies: Design, synthesis, X-ray crystal structures, DFT, and TD-DFT/PCM calculations. ACS Omega.

Ahmed, E. A., Elgemeie, G. H., & Azzam, R. A. (2023). Synthesis of new sulfapyrimidine and pyrazolo[1,5-a]pyrimidine derivatives. Synthetic Communications.

Khedr, M. A., Zaghary, W. A., Elsherif, G. E., Azzam, R. A., & Elgemeie, G. H. (2023). Purine analogs: Synthesis, evaluation and molecular dynamics of pyrazolopyrimidines-based benzothiazole as anticancer and antimicrobial CDK inhibitors. Nucleosides, Nucleotides & Nucleic Acids.

Faiza Abou El-Soud | Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Faiza Abou El-Soud | Formulation Science | Best Researcher Award

College of Nursing-Riyadh King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Prof. Faiza Abou El-Soud is a distinguished scholar and nursing educator whose work focuses on advancing health outcomes, improving the quality of patient care, and enriching the academic development of nursing students. With extensive expertise in nursing education, geriatric care, and psychosocial health, Professor Abou El-Soud has built a research portfolio that bridges theoretical understanding with practical application in healthcare and nursing practice. Her scholarly contributions reflect a commitment to evidence-based nursing, patient-centered care, and the empowerment of healthcare professionals through research-driven insights.Among her notable works is Nursing Students’ Perceptions toward Success and Failure Factors and their Academic Performance: A Descriptive Correlational Study, published in SYLWAN, which explores the academic determinants influencing nursing students’ success, offering valuable perspectives for educators seeking to improve nursing education outcomes. Another significant contribution, Impact of Self-Efficacy Theory on Improving Adherence of Older Adults Patients with Glaucoma’s Medication, published in the Journal of Health, Medicine and Nursing, applies psychological theory to practical nursing interventions, highlighting how self-efficacy principles can enhance medication adherence among older adults suffering from glaucoma.Professor Abou El-Soud has also made important contributions to geriatric health and community nursing through her publication Quality of Life, Self-Rated Health and Social Support among Older Adult in the Saudi Community in The Malaysian Journal of Nursing, where she and her co-authors assess the complex interplay between social support, perceived health, and overall life satisfaction among elderly populations. In another influential study, The Relationship between Health-Related Quality of Life and Burden among Family Caregivers of Elderly Patients Undergoing Hemodialysis in Saudi Arabia, published in the International Journal of Nursing Research, she investigates the emotional and physical challenges faced by caregivers, offering actionable insights to enhance support systems and healthcare strategies.Her collaborative work Impact of the Intrinsic and Extrinsic Motivation Factors on the Turnover Intention among Academic Staff, published in the IOSR Journal of Nursing and Health Science, examines motivational dynamics in academic environments and their influence on faculty retention, thereby contributing to the sustainability and advancement of nursing education institutions.

Profile: Google Scholar

Featured Publications

Salama, R. A., & Abou El-Soud, F. A. (n.d.). Caregiver burden from caring for impaired elderly: A cross-sectional study in rural Lower Egypt. Italian Journal of Public Health, 9(4), 103.

AlAnnaz, W. A. A., Gouda, A. D. K., Abou El-Soud, F. A., & Alanazi, M. R. (n.d.). Obesity prevalence and its impact on maternal and neonatal outcomes among pregnant women: A retrospective cross-sectional study design. Nursing Reports, 14(2), 1236–1250.

Hussein, A. A., & El-Soud, F. A. A. (n.d.). Developing an educational intervention and a standardized clinical assessment tool to promote clinical instructors assessment skills. The Fifteenth National Conference Evidence Based Practice.

Shaqiqi, W., & Abou El-Soud, F. A. (n.d.). The mediating role of social support on the relationship between secondary traumatic stress and burnout of nurses caring for COVID-19 patients: A cross-sectional study. Applied Nursing Research, 79, 151844.

Abou El-Soud, F. A., Alhoraim, S. A., Alammar, B. A., & Alotaibi, R. S. (n.d.). Quality of life, self-rated health and social support among older adult in the Saudi community. The Malaysian Journal of Nursing, 11(3), 13–25.

Al-Shehhi, M. S. M., & El-Soud, F. A. A. (n.d.). Factors affecting quality of life in patients with end-stage renal disease on hemodialysis, Ras Al Khaimah – United Arab Emirates. Journal of Health, Medicine and Nursing, 220–238.

Abou-El-Soud, F. A., Mohamed, H. F., & Prince, J. (n.d.). The effectiveness of training workshop in changing the tutors’ knowledge and attitude towards the integration of problem-based learning into nursing curriculum. International Journal of Nursing, 5.

Maria José García | Gastrointestinal Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Mrs. Maria José García | Gastrointestinal Pharmacology | Best Researcher Award

Hospital Universitario Marqués de Valdecilla | Spain

Mrs. María José García is a distinguished gastroenterologist renowned for her pioneering contributions to the understanding and treatment of inflammatory bowel diseases (IBD) and related gastrointestinal disorders. Currently serving as FEA Digestivo at the Hospital de Laredo, she has earned recognition as an accomplished clinician, educator, and researcher, with a strong commitment to advancing evidence-based gastroenterology. Her academic journey began with a degree in Medicine and Surgery from the University of Salamanca, followed by doctoral training in Biomedicine and Health Sciences at the University of Cantabria. This academic foundation, combined with her dedication to clinical excellence, has positioned her among the most respected figures in the field of digestive health.Her professional path includes prestigious international fellowships at Saint-Antoine Hospital in Paris and the Academic Medical Center in Amsterdam, where she deepened her expertise in the diagnosis and management of complex gastrointestinal conditions. These experiences allowed her to collaborate with leading European experts and integrate cutting-edge therapeutic innovations into clinical practice. Mrs. García’s research has been instrumental in shaping modern therapeutic approaches for IBD, particularly in evaluating biologic agents, third-line rescue therapies, and the withdrawal of antitumour necrosis factor treatments in patients achieving remission.Throughout her career, she has authored and co-authored numerous high-impact scientific articles published in prestigious journals such as Gut, Alimentary Pharmacology & Therapeutics, Therapeutic Advances in Gastroenterology, and Digestive and Liver Disease. Her most influential works have examined topics including inflammatory pouch disorders, safety and efficacy of advanced biologic therapies, and comparative analyses between novel treatment modalities for Crohn’s disease and ulcerative colitis. These studies have contributed valuable insights into optimizing patient care and personalizing treatment strategies across diverse clinical settings.Mrs. García’s scientific impact is underscored by an impressive record of 656 citations from 602 documents, 48 published papers, and an h-index of 14, reflecting both the quality and reach of her research. Her work continues to influence the global gastroenterology community, inspiring ongoing innovation and collaboration. Beyond research, she actively engages in knowledge dissemination through national and international conferences, promoting the integration of clinical practice with scientific discovery. Mrs. María José García stands as a model of excellence in gastroenterology—uniting clinical skill, academic rigor, and compassionate care to enhance the lives of patients worldwide.

Profile: Scopus

Featured Publications

Authors. (2025). Persistence, effectiveness, and safety of upadacitinib in Crohn’s disease and ulcerative colitis in real life: Results from a Spanish nationwide study (Ureal Study). American Journal of Gastroenterology.

Authors. (2025). Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: A randomised placebo-controlled clinical trial of GETECCU. Gut.

Authors. (2025). Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU. Digestive and Liver Disease.

Authors. (2025). Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics. Frontiers in Cellular and Infection Microbiology.

Feng Jiang | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Feng Jiang | Cardiovascular Pharmacology | Best Researcher Award

Stanford University | United States

Dr. Feng Jiang is a highly accomplished postdoctoral researcher at Stanford University, specializing in uncovering the mechanisms and risk factors of human autoimmune diseases. His research focuses on performing experiments and bioinformatic analyses on genetic and RNA-seq data to identify key disease mechanisms and develop therapeutics targeting these pathways. He has also established predictive models based on risk factors to enable early diagnosis of autoimmune conditions. Prior to his postdoctoral work, Dr. Jiang completed his Ph.D. at the University of Rochester, where he conducted extensive research targeting profibrotic genes to combat cardiac fibrosis. His work involved identifying common regulators controlling the expression of profibrotic genes, inhibiting their activity in animal models, and exploring the regulation of mRNA translation in cancer and heart disease. Additionally, he investigated the role of microRNAs in disease, identifying key microRNAs involved in disease progression and their potential as biomarkers for diagnosis and monitoring.Dr. Jiang also gained international research experience as a research fellow at Yat-sen University, where he executed sequencing library construction and established analysis pipelines for human and mouse samples. During his undergraduate studies at Wuhan University, he investigated the role of the gene GLIS2 in cancer progression using CRISPR/Cas9 gene editing techniques.He has contributed significantly to the scientific literature with numerous impactful publications, including works such as RNA Binding Protein PRRC2B Mediates Translation of Specific mRNAs and Regulates Cell Cycle Progression, Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis, Mammalian RNA Switches: Molecular Rheostats in Gene Regulation, Disease, and Medicine, MicroRNA574 Regulates FAM210A Expression and Influences Pathological Cardiac Remodeling, Correlation Between Severity of Spinal Stenosis and Multifidus Atrophy in Degenerative Lumbar Spinal Stenosis, Usage of Procalcitonin and sCD14-ST as Diagnostic Markers for Postoperative Spinal Infection, Correlations Between Serum P2X7, Vitamin A, 25-Hydroxy Vitamin D, and Mycoplasma Pneumoniae Pneumonia, Disruption of Tdrd5 Decouples the Stepwise Processing of Long Precursor Transcripts During Pachytene PIWI-Interacting RNA Biogenesis, and Cardiomyocyte-Specific Loss of Glutamyl-Prolyl-tRNA Synthetase Leads to Disturbed Protein Homeostasis and Dilated Cardiomyopathy.

Profile: Google Scholar

Featured Publications

Jiang, F., Hedaya, O. M., Khor, E. S., Wu, J., Auguste, M., & Yao, P. (n.d.). RNA binding protein PRRC2B mediates translation of specific mRNAs and regulates cell cycle progression. Nucleic Acids Research.

Wu, J., Subbaiah, K. C. V., Xie, L. H., Jiang, F., Khor, E. S., Mickelsen, D., Myers, J. R., Tang, W. H. W., & Yao, P. (n.d.). Glutamyl-prolyl-tRNA synthetase regulates proline-rich pro-fibrotic protein synthesis during cardiac fibrosis. Circulation Research.

Wu, J., Subbaiah, K. C. V., Jiang, F., Hedaya, O., Mohan, A., Yang, T., Welle, K., Ghaemmaghami, S., Tang, W. H. W., Small, E., Yan, C., & Yao, P. (n.d.). MicroRNA-574 regulates FAM210A expression and influences pathological cardiac remodeling. EMBO Molecular Medicine.

Subbaiah, K. C. V., Hedaya, O., Wu, J., Jiang, F., & Yao, P. (n.d.). Mammalian RNA switches: Molecular rheostats in gene regulation, disease, and medicine. Computational and Structural Biotechnology Journal.

Hedaya, O. M., Venkata Subbaiah, K. C., Jiang, F., Xie, L. H., Wu, J., Khor, E. S., Zhu, M., Mathews, D. H., Proschel, C., & Yao, P. (n.d.). Secondary structures that regulate mRNA translation provide insights for ASO-mediated modulation of cardiac hypertrophy. Nature Communications.

Xia, G., Li, X., Shang, Y., Fu, B., Jiang, F., Liu, H., & Qiao, Y. (n.d.). Correlation between severity of spinal stenosis and multifidus atrophy in degenerative lumbar spinal stenosis. BMC Musculoskeletal Disorders.

Zhu, X., Li, K., Zheng, J., Xia, G., Jiang, F., Liu, H., & Shi, J. (n.d.). Usage of procalcitonin and sCD14-ST as diagnostic markers for postoperative spinal infection. Journal of Orthopaedics and Traumatology.

Li, W., Li, Y., Jiang, F., & Liu, H. (n.d.). Correlation between serum levels of microRNA-21 and inflammatory factors in patients with chronic heart failure. Medicine.